(Q63816371)

English

Intravenous Enhancin[Co-amoxiclav] Versus Postoperative Enhancin in Prevention of Postadenotonsillectomy Morbidity.

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Single Intraoperative Intravenous Enhancin[Co-amoxiclav] Versus Postoperative Full Oral Course in Prevention of Post Adenotonsillectomy Morbidity:A Randomised Clinical Trial. (English)

0 references

0 references

0 references

May 2008

0 references

end time

October 2008

0 references

number of participants

126

0 references

maximum age

12 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT01267942

0 references

(Q63816371)

Intravenous Enhancin[Co-amoxiclav] Versus Postoperative Enhancin in Prevention of Postadenotonsillectomy Morbidity.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)